Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
11/2007
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/22/2007WO2005037805A3 1,2,4-thiadiazole compounds and pests controlling composition containing the same
11/22/2007US20070270482 Cytotoxic Agents Comprising New C-2 Modified Taxanes
11/22/2007US20070270426 Compounds for the treatment of neurodegenerative disorders
11/22/2007US20070270416 Active Compound Combinations Having Insecticidal and Acaricidal Properties
11/22/2007US20070270415 Benzothiadiazine compounds
11/22/2007US20070270414 Substituted benzoylguanidines, method for production and use thereof as medicament or diagnostic and medicament comprising the same
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/15/2007WO2007095050A3 N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase
11/15/2007WO2007067615A3 Thiadiazole derivatives as antidiabetic agents
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007WO2006122319A3 Histone deacetylase inhibitors
11/15/2007US20070265446 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
11/15/2007US20070265348 Therapeutic guanidines
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/14/2007EP1689231A4 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/13/2007CA2248304C Surface modified carbonate materials
11/08/2007WO2007073503A3 Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
11/08/2007US20070259922 Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/08/2007US20070259874 Phosphodiesterase Inhibitors
11/07/2007EP1852428A1 4-cyclopropyl-1,2,3-thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same
11/07/2007EP1851209A2 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
11/07/2007EP1087941B9 Thiolesters and uses thereof
11/07/2007CN101068796A Compounds, compositions and thin films
11/07/2007CN101066972A [1,2,3]-thiobizole derivative and its synthesis process and use
11/06/2007US7291744 N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/01/2007WO2007123718A1 1-HETEROCYCLYLAMINO-2-HYDROXY-3-AMINO-ω-ARYLALKANES
11/01/2007US20070254929 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
10/2007
10/31/2007EP1848707A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007DE102005055355A1 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate 3,6-dihydro-2-oxo-6H- [1,3,4] thiadiazine derivatives
10/31/2007DE102005055354A1 Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine Substituted 5-phenyl-3,6-dihydro-2-oxo-6H- [1,3,4] thiadiazine
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007US7288556 Antiproliferative 1,2,3-thiadiazole compounds
10/30/2007CA2254579C Synthesis of 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole via oxidation of 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole with a molybdenum or tungsten catalyst
10/25/2007US20070249594 Benzothiazine and benzothiadiazine compounds
10/25/2007US20070249593 e.g. 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent
10/24/2007EP1847534A2 Thiadiazoline derivative
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1846372A2 Compounds for inflammation and immune-related uses
10/24/2007CN101061110A Novel insecticides
10/24/2007CN101058574A Benzo [1,2,3] thiadiazoles derivatives, synthesis method and use thereof
10/24/2007CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy
10/23/2007US7285572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis
10/23/2007US7285568 Substituted p-(2-alkoxy-2-acylethyl)biphenyl compounds, e.g., 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; useful in human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases, and diseases associated with lipid metabolism
10/23/2007CA2350905C Imidazo[4,5-b]pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum
10/23/2007CA2254623C Synthesis of 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole via oxidation of 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole with glacial acetic acid
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/18/2007WO2007116374A1 Novel sulfonamide compounds
10/18/2007WO2007054257A3 Indene derivatives, their preparation and use as medicaments
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244119 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases
10/18/2007US20070243416 Amine Compound and Organic Electroluminescent Element Employing the Same
10/18/2007CA2646917A1 Novel sulfonamide compounds
10/17/2007EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
10/16/2007US7282519 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
10/16/2007US7282513 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
10/16/2007US7282512 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
10/11/2007WO2007115058A2 Thiadiazolidinone inhibitors of ptpase
10/11/2007US20070238882 Process for Preparing Nitrooxy Esters, Nitrooxy Thioesters Nitrooxy Carbonates and Nitrooxy Thiocarbinates, Intermediates Useful in Said Process and Preparation Thereof
10/11/2007US20070238766 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238740 Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
10/11/2007CA2647472A1 Organic compounds
10/10/2007EP1841749A1 Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
10/10/2007EP1487829B1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
10/09/2007US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279444 for controlling undesirable plants
10/04/2007US20070232620 N-3-chlorobenzyl-3-amino-1H-indazole-5-carboxamide; 3-aminoindazoles; glucocorticoid-depedent kinase (SGK) inhibitors; SGK-induced diseases; diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, fibrosis; inflammatory agents
10/03/2007EP1838308A1 [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
10/03/2007EP1519932B1 Bisarylsulfonamide compounds and their use in cancer therapy
10/03/2007CN101045715A Heterocycle inhibitor for glycogen synthase kinase gsk-3
10/02/2007US7276606 Phenantridine analogues and uses thereof
10/02/2007US7276518 For therapy of neuropathic or chronic pain
10/02/2007CA2210273C Herbicidal compositions based on n-isopropyl-n-(4-fluorophenyl)(5-trifluoromethyl-1,3,4-thiadiazol-2-yloxy)acetamide
09/2007
09/27/2007US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists
09/26/2007EP1836173A2 Anti-inflammatory medicaments
09/25/2007US7273879 3-Thio-5-phenylalkoxy-substituted-1,2,4-thiadiazoles, e.g., 5-benzyloxy-3-methylthio- (or 3-acetoxymethyl)thio-1,2,4-thiadiazole; used for controlling arthropod pests
09/25/2007US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/20/2007US20070219368 Diphenyl(vinyloxyhydrocarbyloxybenzene)sulfonium salts, e.g., p-vinyloxyethoxyphenyldiphenylsulfonium perfluorobutanesulfonate or cyclo(1,3-perfluoropropanedisulfon)imide; acid generating photoinitiators with good photoresist compatability
09/19/2007EP1585734A4 Anti-inflammatory medicaments
09/18/2007USRE39850 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
09/18/2007US7271406 Electron transport agents for organic electronic devices
09/13/2007US20070213380 Thiadiazoline derivative
09/13/2007US20070213379 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/13/2007US20070213329 Sulphones which modulate the action of gammasecretase
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/12/2007EP1831145A1 Substituted oxyarenes
09/12/2007EP1830837A2 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
09/11/2007US7268220 Chelation compounds, radionuclide metal chelate compounds (i.e., complexes) and radiolabeled targeting moieties (i.e., conjugates) formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic purposes
09/11/2007US7268130 Benzothiadiazine compounds
09/11/2007US7268129 Fluorinated benzothiadiazine compounds
09/05/2007EP1828155A2 Diuretic compounds comprising heterocyclic nitric oxide donor groups,compositions and methods of use
09/05/2007EP1827446A2 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
09/05/2007EP0993452B1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 100